@GoldenMindTrade
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ill be buying
Scared money is the easiest. They got a warning statement and will comply now.
Excited for guidelines and regulatuons. I beliwve we will thrive. I see a PR out today explaining how this is a good thing, which it is.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm573443.htm
RMAT= "The FDA will advance the new framework this fall. This comprehensive policy will establish clearer lines around when these regenerative medicine products have sufficient complexity to fall under the agency’s current authority, and then define an efficient process for how these products should be evaluated for safety and effectiveness. The policies will be set forth in a series of guidance documents that are the result of a public process we have held in recent years. The new policy will build upon the agency’s current risk-based, flexible regulatory framework. It will also serve to implement provisions of the 21st Century Cures Act related to regenerative medicine. The FDA has already held public meetings to inform its thinking in these areas, so much of the agency’s approach is already part of the public record. We’ll continue to work with industry and the scientific community to perfect the process for bringing safe and effective treatments to patients.
At the same time, we will also issue a compliance policy that, with the exception of outliers potentially harming public health in a significant way right now, will give current product developers a very reasonable period of time to interact with the FDA in order to determine if they need to submit an application for marketing authorization and to come into the agency and work on a path toward approval. And we will also be developing a novel approach to FDA approval that we believe will allow very small product developers to gain all the benefits of FDA approval through a process that is minimally burdensome and less costly. We’re mindful of the significant promise offered by regenerative medicine, the cost of innovation in this industry, the small companies engaging in these enterprises, and the difficulty of doing FDA registration trials in this field. Our framework will take measure of all of these challenges.
In addition, the FDA will continue to work closely with industry to find other ways to aid in the effort to bring novel therapies to patients as quickly, and as safely, as possible. One of these will include our continued commitment to fully implement the Regenerative Medicine Advanced Therapy (RMAT) designation. This pathway enables regenerative cell therapies to access the FDA’s existing expedited programs to help foster the development and approval of these novel products. Among other things, we plan to include certain gene therapy products that permanently alter tissue and produce a sustained therapeutic benefit as part of the products that will meet the definition of being eligible to come under the pathway enabled by RMAT. This is part of our broader commitment to pursue efforts that will advance innovation in this space. We encourage sponsors who are seeking FDA approval of their product to consider this pathway." -FDA Statement
Cant wait :)
"One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments for some of humanity’s most troubling and intractable maladies"
"As we work to protect Americans from the bad actors, I’m equally committed to doing all we can to help bring to patients more quickly innovative, scientifically proven regenerative cell therapies. For this reason, we’re developing a comprehensive and efficient, science-based policy with the aim of accelerating the proper development of these products."
Insiders buying more and exercising more options. These .03s level seem to be a good level, somethings cooking. Happy Friday everyone..
RTT with FDA guidelines in september :) gonna be exciting when you add a few new clinics
Im talking 5- 10 years about the same time jazz went from pennies to where it is now. Dollar is in near future it looks like
I can see $USRM have a $JAZZ type run if they can get RMAT for myocell :) and if not a few dozen clinics and tens of millions in revenues will be fine too, but with all the recent completed fda safety studies and updates I bet we hear something sooner then later
Interesting, do tell...
I picked up another 100k over the last week. Scared money is the lowest bearing fruit, looks like bottom is in here.
The exposure here will be insane when FDA releases RMAT guidelines
Solid support, wow. Looking for news on new clinics and recent clinical studies.
Solid support of 3 mil plus devolpments underway
Theres too much good going on here. These prices dont make sense to me. $USRM is on track for $10mil+ annual revs for 2018 with a number of other catalysts in the works. We will see what the company is working on soon enough. Im patient here, we already know Kiwait clinic and a few others will be open very soon.
The recent published conplwted clinical trials woth hundreds of patients is also a big thing with FDA RMAT comprehensive guidelines on the way. Excited to see the inpact on the industry and our active * complete clinical trials :)
People cant stop the future kf medicine and with the right to try act, the snowball continues down rhe mountain
The videos are a joke. You need multiple treatments and thats a known fact. Pretty comical to watch to say the least.
Also, your point started with COPD and the video was about liver cirrhosis and a doctor and patiebt that has nothing to do with $USRM haha.
Too much amazing stuff going on here. Even legal meds dont have a good return on patient safety.
Picked up more today =].
Almost all the volume has been over .03
Thats where you are wrong. Myself, being a mid 20s male with hundreds of friends/acuantises that use snapchat, I'd say less then half of them still use facebook. I started using Facebook in 8th grade and used it till about my 2nd year of college, so about 7 years of use. Snapchat started in college for me and lasted 5 years going strong. I dont see snapchat lasting not as long as FB, but much further. My friends and I agree facebook was cool, instagrams great for photos, but we use snapchat everyday" and that is $$$$$$$$$. Cant deny continuous demand. We will see an apple and facebook type run when whatever theyre spending so much R&D on comes to fruition. They didnt go public to be a public camera app. :)
Most people I talk to my age thinks this way. Cheers.
Interested to see where this is headed
I know, but that was not my point. My point is that it seems her main focus is USRM based on her publications and history. She always presents herself as being with US Stem Cells in presentations and always mentions the company and not any other companies, watch her keynotes. I think you got your answer, let me know if you want links
The recently published paper says Kristen Comella US Stem Cell. Not any other org.
3 mil bid seen here.
$USRM on the brink of turn around, 3 mil support hiding pic.twitter.com/gTJ8lmr3nN
— ₿ GoldenMind ₿ (@GoldenMindTrade) August 21, 2017
Ayyyyyy
About 2000 people attended. Now you know.
A run to dime is possible looks like
At least. This valuation is not appropiate if you ask me. Would like to see some information regarding size of Kuwait clinic along with sales per location so we could see growth and track their progress QoQ
Groupthink is a powerful thing, don't let other people's opinions cloud your own. I just added 42k shares at .0249
Seen it so many times, this will close strong.
The PR shows massive interest in a product about to go nation-wide, 83 mil float, revs will continue to grow along with exposure. See everyone in dime land.
Impatience is a curse, thanks all.
Half the volume traded over .026 today while we could barely reach .024s yesterday. Tomorrow should rip through .04s like we did .02s today.
CHeeers :)
They do it to control a moderate rise not a massive eruption but sometimes when yhe slaps come in they cant control it like weve seen. New base at .02s.
Monday more than half the volume(2.6 mil) was traded .01-.015
Tuesday exactly half was traded at .017-.02
And today everything over .02s cant wait to see the 50% range today. Will post after hours
See monday and tuesday here
$TMXN day 1 & 2 of the week analysis, $BITCF financials impressive after hours, skull should go away. $USRM is still most undervalued stock pic.twitter.com/v7RaXaqslF
— ₿ GoldenMind ₿ (@GoldenMindTrade) August 16, 2017
Breakout afternoon coming. The season is starting. This one looks like a monster watch it blow through .029s within 30
Easily. Those slaps on V earlier were very entertaining to watch
It will be fun the next 3 days. I still think bitcoin will hit 5k by friday
Skull gone tomorrow is my guess..thats usually the reason they get put on.
Got .028s today thanks
Looking for $10 mil in revs for 2018. 5 or 6 more clinics opening up this year alone that will be using USRMs services and kits. Cell banking royalties will increase 10x in year 2 of deal with GACP from 2% to ~22%. While FDA lays guidelines for RMAt in a few weeks + a record Q3 on the way :)
It will go away when Q2 comes out, is my guess, seen too many of these, when they make it out of the skull and cross bone though boy is it a life changer. Any remember $THC*Z from .006s to .28 :)
Bitcoin on track for 10k by end of year.
I see this at $4 by Thursday after a dip and bitcoin reaches 5k
Was thinking wednesday